IPP Bureau
J. B. Chemicals & Pharmaceuticals announces DJSI score of 77
By IPP Bureau - March 06, 2025
This achievement underscores the company’s steadfast commitment to sustainability, corporate responsibility, and ESG excellence
Zydus receives final approval from USFDA for Dasatinib Tablets
By IPP Bureau - March 06, 2025
Dasatinib is indicated for the treatment of newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) in chronic phase
Zydus Lifesciences launches ANVIMO
By IPP Bureau - March 06, 2025
ANVIMO will be available in dosages of 240 mg and 480 mg
Auro Vaccines terminates license agreement with Hilleman Laboratories Singapore
By IPP Bureau - March 06, 2025
This termination of Agreement will not have any significant impact on the company and/or its subsidiaries or its financials
Need for enhancing capacity building of medical officers to achieve desired results of healthcare schemes at the grassroot level: J. P. Nadda
By IPP Bureau - March 05, 2025
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
Unichem Laboratories receives 4 observations from USFDA for Pithampur API facility
By IPP Bureau - March 05, 2025
The company will provide the necessary response on these observations to USFDA within stipulated 15 days
Lucas Meyer Cosmetics by Clariant to launch honey-based skin repair solution ‘Melicica’
By IPP Bureau - March 05, 2025
Melicica has potential applications in skin repair, scar and acne-prone skin care, tone evening and brightening, texture improvement, baby care, sensitive skin solutions, post-procedure recovery and stretch mark care
Natco Pharma appoints Bhimrao Dattu Jadhav as Senior VP – Operations (Formulations) for Pharma Division – Kothur
By IPP Bureau - March 04, 2025
Jadhav has completed his B.Pharmacy and is having 30+ years of rich experience in operation management in pharmaceutical Industry
Metropolis Healthcare to acquire Agra's Scientific Pathology
By IPP Bureau - March 04, 2025
Metropolis Clinical Pathology will acquire and operate all laboratories and collection centers of Scientific Pathology in Agra and neighbouring towns through a slump sale transaction
Zydus and Gates Foundation to develop world’s first combination vaccine to offer protection against shigellosis and typhoid
By IPP Bureau - March 04, 2025
Zydus will carry out early-stage development, animal immunogenicity studies and regulatory preclinical toxicology studies for this combination vaccine
GlaxoSmithkline Pharmaceuticals appoints Carson Dalton as Executive VP - Communications and Government Affairs
By IPP Bureau - March 04, 2025
Carson brings with him over two decades of experience in Communications, Public Affairs, and Sustainability
Biocon Academy conducts 9th Graduation Day
By IPP Bureau - March 04, 2025
Notably, 36 female students have been placed in Production and Manufacturing roles, reflecting the growing representation of women in core biotech operations
Senores Pharmaceuticals acquires 14 ANDAs from Dr. Reddy’s Laboratories
By IPP Bureau - March 04, 2025
The basket acquired, comprises of 13 ANDAs, which are approved by the USFDA and 1 ANDA, which is pending approval from the USFDA
